• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依赖Plk1的磷酸化作用在细胞周期进程中调节DNA拓扑异构酶IIα的功能。

Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.

作者信息

Li Hongchang, Wang Yun, Liu Xiaoqi

机构信息

Department of Biochemistry and the Cancer Center, Purdue University, 175 S. University Street, West Lafayette, IN 47907, USA.

出版信息

J Biol Chem. 2008 Mar 7;283(10):6209-21. doi: 10.1074/jbc.M709007200. Epub 2008 Jan 2.

DOI:10.1074/jbc.M709007200
PMID:18171681
Abstract

Plk1 (Polo-like kinase 1) has been documented as a critical regulator of many mitotic events. However, increasing evidence supports the notion that Plk1 might also have functions outside of mitosis. Using biochemical fractionation and RNA interference approaches, we found that Plk1 was required for both G(1)/S and G(2)/M phases and that DNA topoisomerase IIalpha (topoIIalpha) was a potential target for Plk1 in both interphase and mitosis. Plk1 phosphorylates Ser(1337) and Ser(1524) of topoIIalpha. Overexpression of an unphosphorylatable topoIIalpha mutant led to S phase arrest, suggesting that Plk1-associated phosphorylation first occurs in S phase. Moreover, overexpression of the unphosphorylatable topoIIalpha mutant activated the ATM/R-dependent DNA damage checkpoint, probably due to reduced catalytic activity of topoIIalpha, and resulted in accumulation of catenated DNA. Finally, we showed that wild type topoIIalpha, but not the unphosphorylatable mutant, was able to rescue topoIIalpha depletion-induced defects in sister chromatid segregation, indicating that Plk1-associated phosphorylation is essential for the functions of topoIIalpha in mitosis.

摘要

Polo样激酶1(Plk1)已被证明是许多有丝分裂事件的关键调节因子。然而,越来越多的证据支持Plk1可能在有丝分裂之外也具有功能这一观点。利用生化分级分离和RNA干扰方法,我们发现Plk1在G1/S期和G2/M期均是必需的,并且DNA拓扑异构酶IIα(topoIIα)在间期和有丝分裂期都是Plk1的潜在靶点。Plk1使topoIIα的Ser(1337)和Ser(1524)位点磷酸化。不可磷酸化的topoIIα突变体的过表达导致S期停滞,这表明与Plk1相关的磷酸化首先发生在S期。此外,不可磷酸化的topoIIα突变体的过表达激活了ATM/R依赖性DNA损伤检查点,这可能是由于topoIIα的催化活性降低所致,并导致连环DNA的积累。最后,我们表明野生型topoIIα能够挽救topoIIα缺失诱导的姐妹染色单体分离缺陷,而不可磷酸化的突变体则不能,这表明与Plk1相关的磷酸化对于topoIIα在有丝分裂中的功能至关重要。

相似文献

1
Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.依赖Plk1的磷酸化作用在细胞周期进程中调节DNA拓扑异构酶IIα的功能。
J Biol Chem. 2008 Mar 7;283(10):6209-21. doi: 10.1074/jbc.M709007200. Epub 2008 Jan 2.
2
Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.Geminin 过表达可阻止拓扑异构酶 IIα 染色体的解连环,导致人乳腺上皮细胞非整倍体。
Breast Cancer Res. 2011 May 19;13(3):R53. doi: 10.1186/bcr2884.
3
NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOIIα-mediated decatenation checkpoint.NFBD1/MDC1 由 PLK1 磷酸化,并通过调节 TOPOIIα 介导的解连环检查点来控制 G2/M 期转换。
PLoS One. 2013 Dec 11;8(12):e82744. doi: 10.1371/journal.pone.0082744. eCollection 2013.
4
Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.有丝分裂 DNA 损伤反应:Polo 样激酶-1 通过 ATM-Chk1 途径去磷酸化。
Cell Cycle. 2010 Jun 15;9(12):2389-98. doi: 10.4161/cc.9.12.11904.
5
Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1.Plk3在苏氨酸1342位点使拓扑异构酶IIα磷酸化,该位点不被Plk1识别。
Biochem J. 2008 Apr 1;411(1):27-32. doi: 10.1042/BJ20071394.
6
Topoisomerase IIalpha maintains genomic stability through decatenation G(2) checkpoint signaling.拓扑异构酶 IIalpha 通过解链 G(2)检验点信号维持基因组稳定性。
Oncogene. 2010 Aug 26;29(34):4787-99. doi: 10.1038/onc.2010.232. Epub 2010 Jun 21.
7
Phosphorylation of Plk1 at S137 and T210 is inhibited in response to DNA damage.响应DNA损伤时,Plk1在S137和T210位点的磷酸化受到抑制。
Cell Cycle. 2005 Jan;4(1):166-71. doi: 10.4161/cc.4.1.1348. Epub 2005 Jan 5.
8
PIASy-dependent SUMOylation regulates DNA topoisomerase IIalpha activity.PIASy 依赖性 SUMOylation 调节 DNA 拓扑异构酶 IIα 活性。
J Cell Biol. 2010 Nov 15;191(4):783-94. doi: 10.1083/jcb.201004033.
9
Polo-like kinase 1 inactivation following mitotic DNA damaging treatments is independent of ataxia telangiectasia mutated kinase.有丝分裂期DNA损伤处理后Polo样激酶1的失活与共济失调毛细血管扩张症突变激酶无关。
Mol Cancer Res. 2004 Jul;2(7):417-26.
10
ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.ATR通过抑制Plk1激酶来执行拓扑异构酶II依赖性的G2期检查点。
J Biol Chem. 2002 Sep 27;277(39):36832-8. doi: 10.1074/jbc.M206109200. Epub 2002 Jul 29.

引用本文的文献

1
Transcriptomic Analyses of Ovarian Clear Cell Carcinoma Spheroids Reveal Distinct Proliferative Phenotypes and Therapeutic Vulnerabilities.卵巢透明细胞癌球体的转录组分析揭示了不同的增殖表型和治疗脆弱性。
Cells. 2025 May 27;14(11):785. doi: 10.3390/cells14110785.
2
Patulin and Xestoquinol are inhibitors of DNA topoisomerase 1.棒曲霉素和异球喹诺醇是DNA拓扑异构酶1的抑制剂。
Proc Natl Acad Sci U S A. 2025 Apr 29;122(17):e2421167122. doi: 10.1073/pnas.2421167122. Epub 2025 Apr 24.
3
Bioinformatic Analysis of Topoisomerase IIα Reveals Interdomain Interdependencies and Critical C-Terminal Domain Residues.
拓扑异构酶 IIα 的生物信息学分析揭示了结构域间的相互依赖性和关键 C 末端结构域残基。
Int J Mol Sci. 2024 May 23;25(11):5674. doi: 10.3390/ijms25115674.
4
Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression.磷酸化依赖性去泛素化酶 OTUD3 调节 YY1 的稳定性并促进结直肠癌的进展。
Cell Death Dis. 2024 Feb 13;15(2):137. doi: 10.1038/s41419-024-06526-8.
5
Polo-like kinase 1 suppresses lung adenocarcinoma immunity through necroptosis.Polo样激酶1通过坏死性凋亡抑制肺腺癌免疫。
Oncol Res. 2023 Sep 15;31(6):937-953. doi: 10.32604/or.2023.030933. eCollection 2023.
6
Regulation of the mitotic chromosome folding machines.有丝分裂染色体折叠机器的调控。
Biochem J. 2022 Oct 28;479(20):2153-2173. doi: 10.1042/BCJ20210140.
7
PLK1-mediated phosphorylation of PPIL2 regulates HR CtIP.PLK1介导的PPIL2磷酸化调节同源重组中的CtIP。
Front Cell Dev Biol. 2022 Aug 25;10:902403. doi: 10.3389/fcell.2022.902403. eCollection 2022.
8
Present and Future Perspective on PLK1 Inhibition in Cancer Treatment.癌症治疗中PLK1抑制的现状与未来展望。
Front Oncol. 2022 Jun 2;12:903016. doi: 10.3389/fonc.2022.903016. eCollection 2022.
9
The interplay between DNA topoisomerase 2α post-translational modifications and drug resistance.DNA拓扑异构酶2α翻译后修饰与耐药性之间的相互作用。
Cancer Drug Resist. 2020 Feb 27;3(2):149-160. doi: 10.20517/cdr.2019.114. eCollection 2020.
10
Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21.人源拓扑异构酶 II 因 ATP 耗竭发生核仁易位及其被 RNA 聚合酶 I 抑制剂 BMH-21 破坏
Sci Rep. 2021 Nov 2;11(1):21533. doi: 10.1038/s41598-021-00958-4.